FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for CARAFATE (sucralfate). This approval updates the product's labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Gastritis
• Peptic Ulcer Disease

Drugs mentioned

• CARAFATE (sucralfate)

Snippet

SUPPL AP for CARAFATE (SUCRALFATE)